Literature DB >> 10707430

Mechanisms of fatal opioid overdose.

J M White1, R J Irvine.   

Abstract

There has been increasing recognition of the problem of fatal opioid overdose. This review examines the pharmacological basis of respiratory depression following opioid administration. Respiration is controlled principally through medullary respiratory centres with peripheral input from chemoreceptors and other sources. Opioids produce inhibition at the chemoreceptors via mu opioid receptors and in the medulla via mu and delta receptors. While there are a number of neurotransmitters mediating the control of respiration, glutamate and GABA are the major excitatory and inhibitory neurotransmitters, respectively. This explains the potential for interaction of opioids with benzodiazepines and alcohol: both benzodiazepines and alcohol facilitate the inhibitory effect of GABA at the GABAA receptor, while alcohol also decreases the excitatory effect of glutamate at NMDA receptors. Heroin and methadone are the major opioids implicated in fatal overdose. Heroin has three metabolites with opioid activity. Variation in the formation of these metabolites due to genetic factors and the use of other drugs could explain differential sensitivity to overdose. Metabolites of methadone contribute little to its action. However, variation in rate of metabolism due to genetic factors and other drugs used can modify methadone concentration and hence overdose risk. The degree of tolerance also determines risk. Tolerance to respiratory depression is less than complete, and may be slower than tolerance to euphoric and other effects. One consequence of this may be a relatively high risk of overdose among experienced opioid users. While agonist administration modifies receptor function, changes (usually in the opposite direction) also result from use of antagonists. The potential for supersensitivity to opioids following a period of administration of antagonists such as naltrexone warrants further investigation. While our understanding of the pharmacological basis of opioid-related respiratory depression has advanced, better understanding of the role of heroin metabolites, the metabolism of methadone, drug interactions and tolerance would all be of considerable value in knowing how best to respond to this problem.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10707430

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  155 in total

1.  Deaths from drugs of abuse in Sheffield, 1998: the role of prescribed medication.

Authors:  P Oliver; J Keen; G Rowse; N Mathers
Journal:  Br J Gen Pract       Date:  2001-05       Impact factor: 5.386

Review 2.  Strategies for preventing heroin overdose.

Authors:  Karl A Sporer
Journal:  BMJ       Date:  2003-02-22

3.  Injecting drug use in Brighton, Liverpool, and London: best estimates of prevalence and coverage of public health indicators.

Authors:  Matthew Hickman; Vanessa Higgins; Vivian Hope; Mark Bellis; Kate Tilling; Angeline Walker; John Henry
Journal:  J Epidemiol Community Health       Date:  2004-09       Impact factor: 3.710

4.  Trends in Prescribed Central Nervous System Depressant Medications Among Adults Who Regularly Consume Alcohol: United States 1999 to 2014.

Authors:  Jacob T Borodovsky; Melissa J Krauss; Tingying Chi; Laura J Bierut; Richard A Grucza
Journal:  Alcohol Clin Exp Res       Date:  2019-05-28       Impact factor: 3.455

5.  Characterizing profiles of polysubstance use among high school students in Baltimore, Maryland: A latent class analysis.

Authors:  Kristin E Schneider; Sherri-Chanelle Brighthaupt; Abigail K Winiker; Renee M Johnson; Rashelle J Musci; Sabriya L Linton
Journal:  Drug Alcohol Depend       Date:  2020-04-25       Impact factor: 4.492

Review 6.  Alcohol and Opioid Use, Co-Use, and Chronic Pain in the Context of the Opioid Epidemic: A Critical Review.

Authors:  Katie Witkiewitz; Kevin E Vowles
Journal:  Alcohol Clin Exp Res       Date:  2018-02-06       Impact factor: 3.455

7.  Emergency naloxone for heroin overdose.

Authors:  John Strang; Michael Kelleher; David Best; Soraya Mayet; Victoria Manning
Journal:  BMJ       Date:  2006-09-23

8.  All-cause, drug-related, and HIV-related mortality risk by trajectories of jail incarceration and homelessness among adults in New York City.

Authors:  Sungwoo Lim; Tiffany G Harris; Denis Nash; Mary Clare Lennon; Lorna E Thorpe
Journal:  Am J Epidemiol       Date:  2015-02-05       Impact factor: 4.897

9.  Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands.

Authors:  Yi Zheng; Samuel Obeng; Huiqun Wang; Abdulmajeed M Jali; Bharath Peddibhotla; Dwight A Williams; Chuanchun Zou; David L Stevens; William L Dewey; Hamid I Akbarali; Dana E Selley; Yan Zhang
Journal:  J Med Chem       Date:  2019-01-11       Impact factor: 7.446

Review 10.  [CNS metabolism in high-risk drug abuse, German version : Insights gained from 1H- and 31P MRS and PET].

Authors:  S V Bodea
Journal:  Radiologe       Date:  2017-06       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.